학술논문
Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials
Document Type
Short Communication
Author
Source
In Journal of Cystic Fibrosis July 2023 22(4):652-655
Subject
Language
ISSN
1569-1993